Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies

Based on important biological effects associated with xanthine and thiazolidine-4-one moieties, especially hypoglycemic and antioxidant, new xanthine derivatives with thiazolidine-4-one scaffold (XTDs, 6a-k) have been synthesized and reported by our research group, as new potential multitarget antid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of drug delivery science and technology 2020-12, Vol.60, p.102091, Article 102091
Hauptverfasser: Constantin, Sandra Madalina, Lupascu, Florentina Geanina, Apotrosoaei, Maria, Focsa, Alin Viorel, Vasincu, Ioana Mirela, Confederat, Luminita Georgeta, Dimitriu, Gabriel, Lupusoru, Catalina Elena, Routier, Sylvain, Buron, Frederic, Profire, Lenuta
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 102091
container_title Journal of drug delivery science and technology
container_volume 60
creator Constantin, Sandra Madalina
Lupascu, Florentina Geanina
Apotrosoaei, Maria
Focsa, Alin Viorel
Vasincu, Ioana Mirela
Confederat, Luminita Georgeta
Dimitriu, Gabriel
Lupusoru, Catalina Elena
Routier, Sylvain
Buron, Frederic
Profire, Lenuta
description Based on important biological effects associated with xanthine and thiazolidine-4-one moieties, especially hypoglycemic and antioxidant, new xanthine derivatives with thiazolidine-4-one scaffold (XTDs, 6a-k) have been synthesized and reported by our research group, as new potential multitarget antidiabetic drugs. The goal of this work was to evaluate the in vivo antidiabetic potential and safety profile of the most proper XTDs (6c, 6e) and their chitosan based formulations, CS-XTDs (CS-6c, CS-6e) selected based on previous results in terms of their in vitro antioxidant effects and physic-chemical characteristics. Using a streptozotocin-induced diabetes model, the hypoglycemic effect (postprandial glycemia and glycated hemoglobin), biochemical markers of liver and kidney function, as well as hematological markers have been evaluated. The effect on lipid profile and clinical parameters (body weight, food, and water intake) has been also monitored. Moreover, the biopharmaceutical characteristics of 6c and 6e were predicted using in silico computerized methods. The treatment of diabetic rats with CS-XTDs, especially CS-6c was associated with appreciable hypoglycemic effect, the values of postprandial glycemia and glycated hemoglobin being similar with pioglitazone, used as reference drug. In addition, the recorded values for liver enzymes (AST, ALT, LDH), bilirubin (direct, total) and kidney biochemical markers (creatinine, uric acid, urea) were also comparable with pioglitazone. Also, CS-6c was associated with good hematological markers and clinical parameters. The results highlighted the efficiency of the developed chitosan delivery system CS-6c for the treatment of diabetes mellitus syndrome, acting as a potential multitarget agent. [Display omitted] •Chitosan proved to be suitable as drug delivery systems for diabetes mellitus therapy.•Xanthine-thiazolidine-4-one derivatives showed improved hypoglycemic effect.•Chloro substituent showed a favorable influence for hypoglycemic effect.•Improvement of renal, liver and cardiovascular damage specific to diabetes mellitus.
doi_str_mv 10.1016/j.jddst.2020.102091
format Article
fullrecord <record><control><sourceid>elsevier_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04451428v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1773224720313800</els_id><sourcerecordid>S1773224720313800</sourcerecordid><originalsourceid>FETCH-LOGICAL-c337t-d3cc0b6fae6e0d259604fc5abc440b6a55fbd88ec8f058add787b5403effb9673</originalsourceid><addsrcrecordid>eNp9kM9KAzEQh_egYKl9Ai-5etia7Gb_VPBQilqh4EXPIZtM6JRtUpK4ur6D72xqxaOXCfNjvgnzZdkVo3NGWX2zm--0DnFe0OKYFHTBzrIJa5oyLwreXGSzEHaUUtZQxovFJPta2ogaZQcRFQFjQMVApNUkSANxJAfvDPZAnCFqi9EFaYmGHgfwIwljiLAPpHdSgybvGLfEwjv5kDZu0UKeqvx0ffohNTx3FhLscZAxLQi3BC0ZcHAkxDeNEC6zcyP7ALPfd5q9Pty_rNb55vnxabXc5Kosm5jrUina1UZCDVQX1aKm3KhKdorzlMuqMp1uW1CtoVUrtW7apqs4LdN93aJuyml2fdq7lb04eNxLPwonUayXG3HMKOdVEtQOLM2Wp1nlXQgezB_AqDhKFzvxI10cpYuT9ETdnShIZwwIXgSFYBVo9Emx0A7_5b8Bm2ORZg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies</title><source>Alma/SFX Local Collection</source><creator>Constantin, Sandra Madalina ; Lupascu, Florentina Geanina ; Apotrosoaei, Maria ; Focsa, Alin Viorel ; Vasincu, Ioana Mirela ; Confederat, Luminita Georgeta ; Dimitriu, Gabriel ; Lupusoru, Catalina Elena ; Routier, Sylvain ; Buron, Frederic ; Profire, Lenuta</creator><creatorcontrib>Constantin, Sandra Madalina ; Lupascu, Florentina Geanina ; Apotrosoaei, Maria ; Focsa, Alin Viorel ; Vasincu, Ioana Mirela ; Confederat, Luminita Georgeta ; Dimitriu, Gabriel ; Lupusoru, Catalina Elena ; Routier, Sylvain ; Buron, Frederic ; Profire, Lenuta</creatorcontrib><description>Based on important biological effects associated with xanthine and thiazolidine-4-one moieties, especially hypoglycemic and antioxidant, new xanthine derivatives with thiazolidine-4-one scaffold (XTDs, 6a-k) have been synthesized and reported by our research group, as new potential multitarget antidiabetic drugs. The goal of this work was to evaluate the in vivo antidiabetic potential and safety profile of the most proper XTDs (6c, 6e) and their chitosan based formulations, CS-XTDs (CS-6c, CS-6e) selected based on previous results in terms of their in vitro antioxidant effects and physic-chemical characteristics. Using a streptozotocin-induced diabetes model, the hypoglycemic effect (postprandial glycemia and glycated hemoglobin), biochemical markers of liver and kidney function, as well as hematological markers have been evaluated. The effect on lipid profile and clinical parameters (body weight, food, and water intake) has been also monitored. Moreover, the biopharmaceutical characteristics of 6c and 6e were predicted using in silico computerized methods. The treatment of diabetic rats with CS-XTDs, especially CS-6c was associated with appreciable hypoglycemic effect, the values of postprandial glycemia and glycated hemoglobin being similar with pioglitazone, used as reference drug. In addition, the recorded values for liver enzymes (AST, ALT, LDH), bilirubin (direct, total) and kidney biochemical markers (creatinine, uric acid, urea) were also comparable with pioglitazone. Also, CS-6c was associated with good hematological markers and clinical parameters. The results highlighted the efficiency of the developed chitosan delivery system CS-6c for the treatment of diabetes mellitus syndrome, acting as a potential multitarget agent. [Display omitted] •Chitosan proved to be suitable as drug delivery systems for diabetes mellitus therapy.•Xanthine-thiazolidine-4-one derivatives showed improved hypoglycemic effect.•Chloro substituent showed a favorable influence for hypoglycemic effect.•Improvement of renal, liver and cardiovascular damage specific to diabetes mellitus.</description><identifier>ISSN: 1773-2247</identifier><identifier>DOI: 10.1016/j.jddst.2020.102091</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Chemical Sciences ; Chitosan ; Diabetes mellitus ; Drug delivery systems ; Medicinal Chemistry ; Microparticles ; Organic chemistry ; Streptozotocin ; Thiazolidine-4-one scaffold</subject><ispartof>Journal of drug delivery science and technology, 2020-12, Vol.60, p.102091, Article 102091</ispartof><rights>2020 Elsevier B.V.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c337t-d3cc0b6fae6e0d259604fc5abc440b6a55fbd88ec8f058add787b5403effb9673</citedby><cites>FETCH-LOGICAL-c337t-d3cc0b6fae6e0d259604fc5abc440b6a55fbd88ec8f058add787b5403effb9673</cites><orcidid>0000-0001-5773-1515 ; 0000-0002-2823-0591</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27903,27904</link.rule.ids><backlink>$$Uhttps://hal.science/hal-04451428$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Constantin, Sandra Madalina</creatorcontrib><creatorcontrib>Lupascu, Florentina Geanina</creatorcontrib><creatorcontrib>Apotrosoaei, Maria</creatorcontrib><creatorcontrib>Focsa, Alin Viorel</creatorcontrib><creatorcontrib>Vasincu, Ioana Mirela</creatorcontrib><creatorcontrib>Confederat, Luminita Georgeta</creatorcontrib><creatorcontrib>Dimitriu, Gabriel</creatorcontrib><creatorcontrib>Lupusoru, Catalina Elena</creatorcontrib><creatorcontrib>Routier, Sylvain</creatorcontrib><creatorcontrib>Buron, Frederic</creatorcontrib><creatorcontrib>Profire, Lenuta</creatorcontrib><title>Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies</title><title>Journal of drug delivery science and technology</title><description>Based on important biological effects associated with xanthine and thiazolidine-4-one moieties, especially hypoglycemic and antioxidant, new xanthine derivatives with thiazolidine-4-one scaffold (XTDs, 6a-k) have been synthesized and reported by our research group, as new potential multitarget antidiabetic drugs. The goal of this work was to evaluate the in vivo antidiabetic potential and safety profile of the most proper XTDs (6c, 6e) and their chitosan based formulations, CS-XTDs (CS-6c, CS-6e) selected based on previous results in terms of their in vitro antioxidant effects and physic-chemical characteristics. Using a streptozotocin-induced diabetes model, the hypoglycemic effect (postprandial glycemia and glycated hemoglobin), biochemical markers of liver and kidney function, as well as hematological markers have been evaluated. The effect on lipid profile and clinical parameters (body weight, food, and water intake) has been also monitored. Moreover, the biopharmaceutical characteristics of 6c and 6e were predicted using in silico computerized methods. The treatment of diabetic rats with CS-XTDs, especially CS-6c was associated with appreciable hypoglycemic effect, the values of postprandial glycemia and glycated hemoglobin being similar with pioglitazone, used as reference drug. In addition, the recorded values for liver enzymes (AST, ALT, LDH), bilirubin (direct, total) and kidney biochemical markers (creatinine, uric acid, urea) were also comparable with pioglitazone. Also, CS-6c was associated with good hematological markers and clinical parameters. The results highlighted the efficiency of the developed chitosan delivery system CS-6c for the treatment of diabetes mellitus syndrome, acting as a potential multitarget agent. [Display omitted] •Chitosan proved to be suitable as drug delivery systems for diabetes mellitus therapy.•Xanthine-thiazolidine-4-one derivatives showed improved hypoglycemic effect.•Chloro substituent showed a favorable influence for hypoglycemic effect.•Improvement of renal, liver and cardiovascular damage specific to diabetes mellitus.</description><subject>Chemical Sciences</subject><subject>Chitosan</subject><subject>Diabetes mellitus</subject><subject>Drug delivery systems</subject><subject>Medicinal Chemistry</subject><subject>Microparticles</subject><subject>Organic chemistry</subject><subject>Streptozotocin</subject><subject>Thiazolidine-4-one scaffold</subject><issn>1773-2247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kM9KAzEQh_egYKl9Ai-5etia7Gb_VPBQilqh4EXPIZtM6JRtUpK4ur6D72xqxaOXCfNjvgnzZdkVo3NGWX2zm--0DnFe0OKYFHTBzrIJa5oyLwreXGSzEHaUUtZQxovFJPta2ogaZQcRFQFjQMVApNUkSANxJAfvDPZAnCFqi9EFaYmGHgfwIwljiLAPpHdSgybvGLfEwjv5kDZu0UKeqvx0ffohNTx3FhLscZAxLQi3BC0ZcHAkxDeNEC6zcyP7ALPfd5q9Pty_rNb55vnxabXc5Kosm5jrUina1UZCDVQX1aKm3KhKdorzlMuqMp1uW1CtoVUrtW7apqs4LdN93aJuyml2fdq7lb04eNxLPwonUayXG3HMKOdVEtQOLM2Wp1nlXQgezB_AqDhKFzvxI10cpYuT9ETdnShIZwwIXgSFYBVo9Emx0A7_5b8Bm2ORZg</recordid><startdate>202012</startdate><enddate>202012</enddate><creator>Constantin, Sandra Madalina</creator><creator>Lupascu, Florentina Geanina</creator><creator>Apotrosoaei, Maria</creator><creator>Focsa, Alin Viorel</creator><creator>Vasincu, Ioana Mirela</creator><creator>Confederat, Luminita Georgeta</creator><creator>Dimitriu, Gabriel</creator><creator>Lupusoru, Catalina Elena</creator><creator>Routier, Sylvain</creator><creator>Buron, Frederic</creator><creator>Profire, Lenuta</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-5773-1515</orcidid><orcidid>https://orcid.org/0000-0002-2823-0591</orcidid></search><sort><creationdate>202012</creationdate><title>Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies</title><author>Constantin, Sandra Madalina ; Lupascu, Florentina Geanina ; Apotrosoaei, Maria ; Focsa, Alin Viorel ; Vasincu, Ioana Mirela ; Confederat, Luminita Georgeta ; Dimitriu, Gabriel ; Lupusoru, Catalina Elena ; Routier, Sylvain ; Buron, Frederic ; Profire, Lenuta</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c337t-d3cc0b6fae6e0d259604fc5abc440b6a55fbd88ec8f058add787b5403effb9673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Chemical Sciences</topic><topic>Chitosan</topic><topic>Diabetes mellitus</topic><topic>Drug delivery systems</topic><topic>Medicinal Chemistry</topic><topic>Microparticles</topic><topic>Organic chemistry</topic><topic>Streptozotocin</topic><topic>Thiazolidine-4-one scaffold</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Constantin, Sandra Madalina</creatorcontrib><creatorcontrib>Lupascu, Florentina Geanina</creatorcontrib><creatorcontrib>Apotrosoaei, Maria</creatorcontrib><creatorcontrib>Focsa, Alin Viorel</creatorcontrib><creatorcontrib>Vasincu, Ioana Mirela</creatorcontrib><creatorcontrib>Confederat, Luminita Georgeta</creatorcontrib><creatorcontrib>Dimitriu, Gabriel</creatorcontrib><creatorcontrib>Lupusoru, Catalina Elena</creatorcontrib><creatorcontrib>Routier, Sylvain</creatorcontrib><creatorcontrib>Buron, Frederic</creatorcontrib><creatorcontrib>Profire, Lenuta</creatorcontrib><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of drug delivery science and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Constantin, Sandra Madalina</au><au>Lupascu, Florentina Geanina</au><au>Apotrosoaei, Maria</au><au>Focsa, Alin Viorel</au><au>Vasincu, Ioana Mirela</au><au>Confederat, Luminita Georgeta</au><au>Dimitriu, Gabriel</au><au>Lupusoru, Catalina Elena</au><au>Routier, Sylvain</au><au>Buron, Frederic</au><au>Profire, Lenuta</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies</atitle><jtitle>Journal of drug delivery science and technology</jtitle><date>2020-12</date><risdate>2020</risdate><volume>60</volume><spage>102091</spage><pages>102091-</pages><artnum>102091</artnum><issn>1773-2247</issn><abstract>Based on important biological effects associated with xanthine and thiazolidine-4-one moieties, especially hypoglycemic and antioxidant, new xanthine derivatives with thiazolidine-4-one scaffold (XTDs, 6a-k) have been synthesized and reported by our research group, as new potential multitarget antidiabetic drugs. The goal of this work was to evaluate the in vivo antidiabetic potential and safety profile of the most proper XTDs (6c, 6e) and their chitosan based formulations, CS-XTDs (CS-6c, CS-6e) selected based on previous results in terms of their in vitro antioxidant effects and physic-chemical characteristics. Using a streptozotocin-induced diabetes model, the hypoglycemic effect (postprandial glycemia and glycated hemoglobin), biochemical markers of liver and kidney function, as well as hematological markers have been evaluated. The effect on lipid profile and clinical parameters (body weight, food, and water intake) has been also monitored. Moreover, the biopharmaceutical characteristics of 6c and 6e were predicted using in silico computerized methods. The treatment of diabetic rats with CS-XTDs, especially CS-6c was associated with appreciable hypoglycemic effect, the values of postprandial glycemia and glycated hemoglobin being similar with pioglitazone, used as reference drug. In addition, the recorded values for liver enzymes (AST, ALT, LDH), bilirubin (direct, total) and kidney biochemical markers (creatinine, uric acid, urea) were also comparable with pioglitazone. Also, CS-6c was associated with good hematological markers and clinical parameters. The results highlighted the efficiency of the developed chitosan delivery system CS-6c for the treatment of diabetes mellitus syndrome, acting as a potential multitarget agent. [Display omitted] •Chitosan proved to be suitable as drug delivery systems for diabetes mellitus therapy.•Xanthine-thiazolidine-4-one derivatives showed improved hypoglycemic effect.•Chloro substituent showed a favorable influence for hypoglycemic effect.•Improvement of renal, liver and cardiovascular damage specific to diabetes mellitus.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.jddst.2020.102091</doi><orcidid>https://orcid.org/0000-0001-5773-1515</orcidid><orcidid>https://orcid.org/0000-0002-2823-0591</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1773-2247
ispartof Journal of drug delivery science and technology, 2020-12, Vol.60, p.102091, Article 102091
issn 1773-2247
language eng
recordid cdi_hal_primary_oai_HAL_hal_04451428v1
source Alma/SFX Local Collection
subjects Chemical Sciences
Chitosan
Diabetes mellitus
Drug delivery systems
Medicinal Chemistry
Microparticles
Organic chemistry
Streptozotocin
Thiazolidine-4-one scaffold
title Antidiabetic effects and safety profile of chitosan delivery systems loaded with new xanthine-thiazolidine-4-one derivatives: in vivo studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T01%3A58%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antidiabetic%20effects%20and%20safety%20profile%20of%20chitosan%20delivery%20systems%20loaded%20with%20new%20xanthine-thiazolidine-4-one%20derivatives:%20in%20vivo%20studies&rft.jtitle=Journal%20of%20drug%20delivery%20science%20and%20technology&rft.au=Constantin,%20Sandra%20Madalina&rft.date=2020-12&rft.volume=60&rft.spage=102091&rft.pages=102091-&rft.artnum=102091&rft.issn=1773-2247&rft_id=info:doi/10.1016/j.jddst.2020.102091&rft_dat=%3Celsevier_hal_p%3ES1773224720313800%3C/elsevier_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S1773224720313800&rfr_iscdi=true